MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jchf.2022.10.002

Медицинская библиотека · JACC. Heart failure · 2022

Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock.

Hernandez-Montfort Jaime, Kanwar Manreet, Sinha Shashank S, Garan A Reshad, Blumer Vanessa, Kataria Rachna, Whitehead Evan H, Yin Michael, Li Borui, Zhang Yijing, Thayer Katherine L, Baca Paulina, Dieng Fatou, Harwani Neil M, Guglin Maya, Abraham Jacob, Hickey Gavin, Nathan Sandeep, Wencker Detlef, Hall Shelley, Schwartzman Andrew, Khalife Wissam, Li Song, Mahr Claudius, Kim Ju, Vorovich Esther, Pahuja Mohit, Burkhoff Daniel, Kapur Navin K

Клиническое исследованиеСтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Heart failure-related cardiogenic shock (HF-CS) remains an understudied distinct clinical entity.

OBJECTIVES

The authors sought to profile a large cohort of patients with HF-CS focused on practical application of the SCAI (Society for Cardiovascular Angiography and Interventions) staging system to define baseline and maximal shock severity, in-hospital management with acute mechanical circulatory support (AMCS), and clinical outcomes.

METHODS

The Cardiogenic Shock Working Group registry includes patients with CS, regardless of etiology, from 17 clinical sites enrolled between 2016 and 2020. Patients with HF-CS (non-acute myocardial infarction) were analyzed and classified based on clinical presentation, outcomes at discharge, and shock severity defined by SCAI stages.

RESULTS

A total of 1,767 patients with HF-CS were included, of whom 349 (19.8%) had de novo HF-CS (DNHF-CS). Patients were more likely to present in SCAI stage C or D and achieve maximum SCAI stage D. Patients with DNHF-CS were more likely to experience in-hospital death and in- and out-of-hospital cardiac arrest, and they escalated more rapidly to a maximum achieved SCAI stage, compared to patients with acute-on-chronic HF-CS. In-hospital cardiac arrest was associated with greater in-hospital death regardless of clinical presentation (de novo: 63% vs 21%; acute-on-chronic HF-CS: 65% vs 17%; both P < 0.001). Forty-five percent of HF-CS patients were exposed to at least 1 AMCS device throughout hospitalization.

CONCLUSIONS

In a large contemporary HF-CS cohort, we identified a greater incidence of in-hospital death and cardiac arrest as well as a more rapid escalation to maximum SCAI stage severity among DNHF-CS. AMCS use in HF-CS was common, with significant heterogeneity among device types. (Cardiogenic Shock Working Group Registry [CSWG]; NCT04682483).

Для цитирования: Hernandez-Montfort Jaime, Kanwar Manreet, Sinha Shashank S, Garan A Reshad, Blumer Vanessa, Kataria Rachna, Whitehead Evan H, Yin Michael, Li Borui, Zhang Yijing, Thayer Katherine L, Baca Paulina, Dieng Fatou, Harwani Neil M, Guglin Maya, Abraham Jacob, Hickey Gavin, Nathan Sandeep, Wencker Detlef, Hall Shelley, Schwartzman Andrew, Khalife Wissam, Li Song, Mahr Claudius, Kim Ju, Vorovich Esther, Pahuja Mohit, Burkhoff Daniel, Kapur Navin K. Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock.. JACC. Heart failure. 2022. DOI: 10.1016/j.jchf.2022.10.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.